All funds

Greenskeeper

Dec 2024 → Jun 2026 · Publishes quarterly · 2 funds

Our archive holds 7 letters from Greenskeeper, behind 4 investment theses and positions in 10 companies. Every quote below is copied verbatim from the letter it came from.

Greenskeeper’s own letters page
7
Letters
10
Companies
1
Moves
4
Theses

What they bought and sold · 1 move

Companies held · 10

Every company Greenskeeper has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 4

  • Intercontinental Exchange, Inc. has strong earnings growth, a defensible franchise in energy markets, and market-leading infrastructure that supports long-term compounding.

    Read the full thesis
  • Elevance Health, Inc. has a strong commercial health insurance franchise, improving cost trends, and potential for an earnings recovery.

    Read the full thesis
  • June 2025

    Novo Nordisk is a leading insulin maker whose growth is currently driven by its GLP-1 franchise, and despite competitive pressures, its pipeline remains undervalued in a growing market.

    Read the full thesis
  • March 2025

    Icon PLC (ICLR) is a leading contract research organization that will benefit from ongoing development of new drugs and medical devices, despite current regulatory uncertainties.

    Read the full thesis

Letter archive · 7

Funds · 2

  • Greenskeeper6
  • GreensKeeper Value Fund1

Get Greenskeeper’s next letter the day it lands

We track Greenskeeper alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans
Share this fund